Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study

CONTEXT: The effect of pegvisomant on IGF1 levels in patients with acromegaly is well documented, but little is known of its long-term impact on comorbidity. AIM: The aim of this retrospective study was to evaluate the effects of long-term pegvisomant therapy on cardiorespiratory and metabolic comor...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Eur J Endocrinol
Egile Nagusiak: Kuhn, Emmanuelle, Maione, Luigi, Bouchachi, Amir, Rozière, Myriam, Salenave, Sylvie, Brailly-Tabard, Sylvie, Young, Jacques, Kamenicky, Peter, Assayag, Patrick, Chanson, Philippe
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Bioscientifica Ltd 2015
Gaiak:
Clinical Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4592912/
https://ncbi.nlm.nih.gov/pubmed/26429918
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EJE-15-0500
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak